Item 8.01 Other Events.

On September 7, 2021, Ortho Clinical Diagnostics Holdings plc (the "Company") issued a press release announcing that one of its shareholders, an affiliate of The Carlyle Group (the "Selling Shareholder"), intends to offer for sale (the "Offering") in an underwritten secondary offering 22,000,000 ordinary shares of the Company, nominal value $0.00001 per share (the "Ordinary Shares"). The Selling Shareholder expects to grant the underwriters an option to purchase up to 3,300,000 additional Ordinary Shares within thirty (30) days from the pricing of the Offering. A copy of this press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Forward Looking Statements

This Current Report on Form 8-K may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements reflect, among other things, our current expectations regarding the Offering, all of which are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements, market trends, or industry results to differ materially from those expressed or implied by such forward-looking statements. Therefore, any statements contained herein that are not statements of historical fact may be forward-looking statements and should be evaluated as such. Without limiting the foregoing, the words as "anticipate," "expect," "suggest," "plan," "believe," "intend," "project," "forecast," "estimates," "targets," "projections," "should," "could," "would," "may," "might," "will," and the negative thereof and similar words and expressions are intended to identify forward-looking statements. Factors that might materially affect such forward looking statements are included in the section entitled "Risk Factors" in our most recent Annual Report on Form 10-K and in other documents that we have filed with, or furnished to, the U.S. Securities and Exchange Commission. Unless legally required, we assume no obligation to update any such forward-looking information to reflect actual results or changes in the factors affecting such forward-looking information.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits.



Exhibit
Number                                  Description
            Press Release issued by Ortho Clinical Diagnostics Holdings plc dated
99.1      September 7, 2021
          Cover Page Interactive Data File (embedded within the Inline XBRL
104       document).








                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses